Clinical trial
Paracetamol Versus Ibuprofen in Premature Infants With Hemodynamically Significant Patent Ductus Arteriosus: a Randomized Clinical Trial
NCT04037514 is registered in ClinicalTrials.gov with Máximo Vento Torres as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Paracetamol Versus Ibuprofen in Premature Infants With Hemodynamically Significant Patent Ductus Arteriosus: a Randomized Clinical Trial
- Lead sponsor
- Máximo Vento Torres
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 7, 2017
- Completion date
- December 18, 2024
- Enrollment
- 133 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
patent ductus arteriosus after premature birth